|
MTFR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.06579991896194E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.715500E-02 |
| Stage1-vs-Stage3 |
1.347970E-01 |
| Stage1-vs-Stage4 |
2.019700E-03 |
| Stage2-vs-Stage3 |
6.937600E-03 |
| Stage2-vs-Stage4 |
6.241500E-04 |
| Stage3-vs-Stage4 |
1.436810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.05589997751099E-11 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
3.687200E-01 |
| Caucasian-vs-Asian |
5.679800E-01 |
| AfricanAmerican-vs-Asian |
6.956600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.106000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
1.61850000000019E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.869800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.076600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.770800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.657800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.867400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.343000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.697800E-02 |
| Classical-VS-Follicular |
5.64760000000275E-05 |
| Classical-VS-Other |
2.142600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.89329999997512E-06 |
| Tall-VS-Other |
7.030400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.700600E-03 |
| Follicular-VS-Normal |
4.20830004177475E-09 |
| Other-VS-Normal |
5.71820000239143E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.202370E-03 |
|
|
